Skip to content

Drug interactions

Basiliximab + Mercaptopurine

Severity: Moderate

Basiliximab and Mercaptopurine: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Basiliximab blocks the IL-2 receptor on activated T cells, and mercaptopurine suppresses lymphocyte proliferation. Together they deepen immunosuppression, which may raise the risk of infection. This pairing is used within transplant protocols.

What this interaction means in plain words

Basiliximab and Mercaptopurine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Basiliximab belongs to Miscellaneous; Mercaptopurine belongs to Oncology.

Evidence level: Moderate

Why it happens

Additive immunosuppression through IL-2 receptor blockade plus inhibition of purine synthesis in lymphocytes.

What to do

Monitor for signs of infection and check blood counts regularly. Keep the combination within an established transplant immunosuppression protocol.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Basiliximab and Mercaptopurine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Basiliximab with Mercaptopurine?

MediHelp rates the interaction as moderate. Basiliximab and Mercaptopurine can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Basiliximab blocks the IL-2 receptor on activated T cells, and mercaptopurine suppresses lymphocyte proliferation. Together they deepen immunosuppression, which may raise the risk of infection. This pairing is used within transplant protocols.

How serious is the interaction between Basiliximab and Mercaptopurine?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for signs of infection and check blood counts regularly. Keep the combination within an established transplant immunosuppression protocol.

What other medicines interact with Mercaptopurine?

MediHelp also lists interactions of Mercaptopurine with, for example, Adenovirus types 4 and 7 live, Azathioprine, Bcg vaccine live. The full list is on the Mercaptopurine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in